Skip to content
← Back to this collection

PUBLICATIONS · 28826616

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Haematol
Publication date
2017 Sep
First author
Holstein SA

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2017 Sep;4(9):e404-e405. doi: 10.1016/S2352-3026(17)30148-5.
    note
    Source null
    related pmid
    28826617
    relationship
    Comment in
  2. citation
    Lancet Haematol. 2018 Aug;5(8):e332. doi: 10.1016/S2352-3026(18)30114-5.
    note
    Source null
    related pmid
    30030067
    relationship
    Erratum in
  3. citation
    Lancet Haematol. 2018 Dec;5(12):e608. doi: 10.1016/S2352-3026(18)30199-6.
    note
    Source null
    related pmid
    30501866
    relationship
    Erratum in

Authors and identifiers

  1. name
    Holstein SA
    type
    Author
  2. name
    Jung SH
    type
    Author
  3. name
    Richardson PG
    type
    Author
  4. name
    Hofmeister CC
    type
    Author
  5. name
    Hurd DD
    type
    Author
  6. name
    Hassoun H
    type
    Author
  7. name
    Giralt S
    type
    Author
  8. name
    Stadtmauer EA
    type
    Author
  9. name
    Weisdorf DJ
    type
    Author
  10. name
    Vij R
    type
    Author
  11. name
    Moreb JS
    type
    Author
  12. name
    Callander NS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Holstein SA
    type
    Author
  2. name
    Jung SH
    type
    Author
  3. name
    Richardson PG
    type
    Author
  4. name
    Hofmeister CC
    type
    Author
  5. name
    Hurd DD
    type
    Author
  6. name
    Hassoun H
    type
    Author
  7. name
    Giralt S
    type
    Author
  8. name
    Stadtmauer EA
    type
    Author
  9. name
    Weisdorf DJ
    type
    Author
  10. name
    Vij R
    type
    Author
  11. name
    Moreb JS
    type
    Author
  12. name
    Callander NS
    type
    Author
bibliography ids
  1. nci-bib-528ad771f3d013689be186d1
book metadata
content sha256
098c18217590b1839f7ee2a182e796ab0556fc8f5e29bd72cbddfe6270df0ef1
document type
citation
dois
  1. 10.1016/S2352-3026(17)30140-0
electronic publication date
display
2017 Aug 17
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28826616
immutable id
pubmed:28826616@098c18217590b1839f7ee2a182e796ab0556fc8f5e29bd72cbddfe6270df0ef1
journal
abbreviation
Lancet Haematol
issn electronic
2352-3026
issn print
Source null
issue
9
name
The Lancet. Haematology
nlm unique id
101643584
pages
e431-e442
volume
4
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Haematol. 2017 Sep;4(9):e404-e405. doi: 10.1016/S2352-3026(17)30148-5.
    note
    Source null
    related pmid
    28826617
    relationship
    Comment in
  2. citation
    Lancet Haematol. 2018 Aug;5(8):e332. doi: 10.1016/S2352-3026(18)30114-5.
    note
    Source null
    related pmid
    30030067
    relationship
    Erratum in
  3. citation
    Lancet Haematol. 2018 Dec;5(12):e608. doi: 10.1016/S2352-3026(18)30199-6.
    note
    Source null
    related pmid
    30501866
    relationship
    Erratum in
outcomes validated
false
pmid
28826616
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
2797ca21a3aa5a9321a59b9a27b3c3564ebade7411d0dc7dffe051215c67085f
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Sep
precision
month
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28826616/
title
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.

Preserved source evidence · Not medical advice